NIH Grant for Opioid Care in Primary Clinics: Ohio University researcher Berkeley Franz won a nearly $4M, four-year NIH award to expand a pilot model that helps primary care providers prescribe medication for opioid use disorder, scaling it across about 40 Ohio and West Virginia clinics with outcome tracking and mentorship support. Ohio Healthcare Access: Ohio University Libraries will add UpToDate starting July 1, giving students and clinicians point-of-care clinical decision support via web and mobile login. Ohio Education Policy: Ohio House advanced a revamped K-12 math bill (SB 19) aimed at improving statewide proficiency after pandemic-era declines, with further Senate approval needed. AI in Schools Catch-Up: A national look at K-12 AI policy shows districts and states scrambling for guardrails, with lawmakers pushing AI literacy, coordinator roles, and teacher training. Local Control for Traffic Cameras: Ohio bills would let residents vote on whether municipalities can use automated traffic enforcement cameras, with rules for new installs and contract changes. Data Centers Under Pressure: Texas Gov. Greg Abbott ordered regulators to require data center developers to cover infrastructure costs and protect consumers, as backlash grows over power and water impacts. Meta’s Workforce Push: Meta announced a $115M “America’s Workforce Academy” to train skilled trades for AI data center buildouts, including free training and job offers in Ohio and other data-center states. Ohio Tech Courts: An Ohio appeals court ruled Google Search isn’t a common carrier, limiting attempts to treat it like a regulated utility. Ohio River Infrastructure: The U.S. Army Corps’ locks-and-dams electrical systems got circuit breaker relay maintenance support from Prime Power troops across multiple states. Ohio Business & Finance: Grocery Outlet reshuffled top leadership with dual EVP appointments, while Solidion closed a $35M private placement to fund commercialization of its extreme-climate battery tech. Public Health Watch: A report highlights FDA scrutiny gaps around peptide weight-loss “retatrutide” sales and hospitalizations tied to unapproved use.